Home › Seizures › Colorado › Aurora
Seizures clinical trials in Aurora, CO
6 studies for Seizures are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Prospective Natural History Study of POLG Disease
RecruitingObservational study
- Children's Hospital Colorado, Aurora
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RecruitingPhase 2/3
- University of Colorado Anschultz Medical Campus, Aurora
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
RecruitingPhase 3
- Praxis Research Site, Aurora
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Colorado Anschutz Medical Campus, Aurora
Pediatric Dose Optimization for Seizures in Emergency Medical Services
RecruitingPhase 3
- University of Colorado, Aurora
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- UC Health University of Colorado Anshutz, Aurora
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA11 studies
- Boston, MA8 studies
- Birmingham, AL7 studies
- Chicago, IL7 studies
- Houston, TX7 studies
- Dallas, TX7 studies
- Cincinnati, OH7 studies
- Miami, FL6 studies
- Durham, NC6 studies
- Clifton, NJ5 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Ovarian Cancer24 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.